Defining Expectations for Infants With Hypoplastic Left Heart Syndrome Who Survive Initial Surgical Palliation

Jason W Greenberg1, Farhan Zafar1, David S Winlaw1

  • 1The Heart Institute, 2518Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Insights

Surgically palliated hypoplastic left heart syndrome patients spend about 10 months outside the hospital in their first year. Understanding factors linked to less time at home can improve care for these complex congenital heart patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Neonatal Outcomes

Background:

  • One-year non-mortality outcomes for hypoplastic left heart syndrome (HLHS) patients undergoing surgical palliation are not well-studied.
  • The metric Days Alive and Outside of Hospital (DAOH) is used to assess these outcomes.

Purpose of the Study:

  • To characterize one-year outcomes for surgically palliated HLHS patients using the DAOH metric.
  • To identify factors associated with lower DAOH in this population.

Main Methods:

  • Utilized the Pediatric Health Information System database for HLHS patients undergoing surgical palliation (Norwood/hybrid and/or heart transplantation [HTx]).
  • Included 2227 patients discharged alive after index neonatal admission, calculating one-year DAOH.
  • Grouped patients into DAOH quartiles for comparative analysis.

Main Results:

  • Median one-year DAOH was 304 days, with a median index admission of 43 days.
  • Lower DAOH quartiles (median 187 days) were associated with higher readmission mortality/hospice discharge (14%) compared to upper quartiles (1%).
  • Factors linked to lower DAOH included interstage hospitalization, index-admission HTx, preterm birth, chromosomal abnormality, later surgery age, and non-white race/ethnicity.

Conclusions:

  • Surgically palliated HLHS infants spend approximately 10 months alive and outside the hospital annually, with significant variability.
  • Identifying factors associated with lower DAOH is crucial for managing expectations and guiding clinical decisions in HLHS care.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22